Psoriasis Psoriasis Psoriasis Area and Severity Index (PASI) Dermatology life quality index (DLQI) Thai herbal formulation
Conditions
Interventions
Thai herbal formulations included three oral preparations: (i) haematic tonic [Angelica dahurica, Angelica sinensis, Plumbago indica, Piper sarmentosum, Atractylodes lancea, Ligusticum sinense, Artemi
Experimental Drug
Thai herbal formulations
Sponsors
Faculty of Traditional Thai Medicine
National Research Council of Thailand and Faculty of Traditional Thai Medicine, Prince of Songkla University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. aged 18 years or older, 2. patients with a clinical diagnosis of psoriasis, 3. patients voluntarily participated in the study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. patients with uncontrolled systemic illness or life-threatening infection, 2. patients who had already undergoing treatment for any chronic skin disease, substance abuse and/or dependence, pregnant or lactating women, 3. patients with psychiatric diseases and self-reported immune-compromised states, 4. patients who had allergic history to any Thai herbal medicines.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of psoriatic lesions, quality-of-life Week 0 and 12 Psoriasis Area and Severity Index (PASI), Dermatology life quality index (DLQI) | — |
Secondary
| Measure | Time frame |
|---|---|
| hematological and safety parameters Week 0 and 12 liver function tests, kidney function tests, and complete blood count tests | — |
Countries
Thailand
Contacts
Public ContactThanyaluck Siriyong
Faculty of Traditional Thai Medicine, Prince of Songkla University
Outcome results
None listed